Red Blood Cell Lifespan

• Register: ClinicalTrials.gov
• Last refreshed on: 3 December 2012
• Main ID: NCT01462071
• Date of registration: 26/10/2011
• Primary sponsor: Renal Research Institute
• Public title: Red Blood Cell Lifespan RBC
• Scientific title: Red Blood Cell Lifespan and Inflammation in Dialysis Patients
• Date of first enrolment: May 2008
• Target sample size: 100
• Recruitment status: Recruiting
• URL: http://clinicaltrials.gov/show/NCT01462071
• Study type: Observational
• Study design: Observational Model: Cohort, Time Perspective: Prospective

Countries of recruitment

United States

Contacts

• Name: Laura Rosales, MD

• Name: Rebecca Apruzzese, MS

• Name: Peter Kotanko, MD
• Affiliation: Renal Research Institute

Key inclusion & exclusion criteria

Inclusion Criteria:

- Age greater than 18 years

- Chronic hemo- or peritoneal dialysis treatment greater than 3 months

Exclusion Criteria:

- Inability to understand the English language and give informed consent for
participation in the study



Age minimum: 18 Years
Age maximum: 88 Years
Gender: Both

Health Condition(s) or Problem(s) studied

Chronic Kidney Disease

Hemodialysis

Primary Outcome(s)

Relationship between inflammation and erythrocyte lifespan [Time Frame: 6 visits during 18 month period]

Secondary Outcome(s)

Evaluate the accuracy of HbA1c and fructosamine measurements for assessment of glucose control [Time Frame: 6 visits during 18 month period]

Secondary ID(s)

039-08

Source(s) of Monetary Support

Please refer to primary and secondary sponsors